CHE  Chemed Corp.

Exchange

NYSE

Sector

Health Care

Industry

Medical/Nursing Services

Market Cap.

1.716B

Vuru Grade

61.38/100

Current Price

$100.89
-3.99 (-3.80%)

Growth Price

$89.34
Overvalued by 11.45%

Stability Price

$102.05
Fairly valued

Company Metrics

  • 20.36 P/E
  • 1.25 P/S
  • 4.13 P/B
  • 5.152 EPS
  • 20.03% Cash ROIC
  • 0.23 Cash Ratio
  • 0.84 / 0.8% Dividend
  • 163,469.00 Avg. Vol.
  • 17.01M Shares
  • 1.716B Market Cap.

Company Description

Chemed Corporation, through its subsidiaries, provides hospice care, and repair and cleaning services in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice services to terminally ill patients. This segment provides hospice services in the areas of routine home care, general inpatient care, continuous care, and Medicare cap. It also offe...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

A Value Investor's Dream: Chemed Corporation
Seeking Alpha - Nov 5, 2013
Chemed Corporation (NYSE:CHE) is the parent company of two subsidies: 1) Roto-Rooter and 2) VITAS. Roto-Rooter operates through 110 company-owned branches and independent contractors, and over 400 franchisees.
Chemed Corporation to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire (press release) - Nov 4, 2014
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2014 Credit Suisse Healthcare Conference on Tuesday, November 11, 2014, at approximately 11:30 a.m.
Chemed Corporation to Present at the 33rd Annual JP Morgan Healthcare ...
MarketWatch - Dec 28, 2006
CINCINNATI, Jan 08, 2015 (BUSINESS WIRE) -- Chemed Corporation CHE, +0.46% today announced that it will deliver a presentation at the 33rd Annual J.P.
Lawsuit on Behalf of Investors in Chemed Corporation (CHE) Announced by ...
GlobeNewswire (press release) - Sep 17, 2013
SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending on behalf of certain purchasers of Chemed Corporation (CHE) common stock over alleged violations of Federal Securities Laws by ...
Chemed Corporation (CHE): Hedge Funds Are Bullish and Insiders Are ... - Insider Monkey (blog)
Chemed Corporation Announces Receipt of False Claims Action Complaint
Business Wire (press release) - May 3, 2013
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation ("Chemed") (NYSE:CHE). On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries in the Western District of Missouri, ...
Chemed Declines Most in Five Years on Medicare Lawsuit - Bloomberg
US sues owner of nation's biggest for-profit hospice chain - Reuters
Chemed Corporation's Board of Directors Authorizes an Additional $100 Million ...
MarketWatch (press release) - Jul 28, 2006
CINCINNATI, Feb 21, 2014 (BUSINESS WIRE) -- Chemed Corporation CHE, -1.00% announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program.
Chemed Corp.: Major Player in Hospice and Plumbing
Seeking Alpha (blog) - Feb 26, 2007
Chemed Corporation (NYSE:CHE), formerly Roto-Rooter, Inc. is headquartered in Cincinnati, Ohio. Publicly traded since 1971, Chemed currently operates in the healthcare field through its Vitas Healthcare Corporation subsidiary, and in the residential ...
Short Interest of Chemed Corporation Drops by -5.1%
Rock Hill Daily - Jan 21, 2015
Chemed Corporation (NYSE:CHE) encountered a drop of 5.1% or -149,031 shares in the short positions. The number dropped from 2,937,020 on December 15,2014 to 2,787,989 on December 31,2014.
Chemed to Report Fourth-Quarter 2014 Earnings February 17, Related ... - Business Wire (press release)
Underperforming Companies for the Week: Chemed Corporation , Gladstone ...
Rock Hill Daily - Jan 20, 2015
Chemed Corporation (NYSE:CHE) has lost 0.92% during the past week and dropped 3.15% in the past 4 weeks. The shares have outperformed the S&P 500 by 0.32% in the past week but underperformed the index by 0.7% in the past 4 weeks.
Disclosure on Insider Transaction: Cancer Genetics Inc , Chemed Corporation
Wall Street Pulse - Jan 6, 2015
Cancer Genetics Inc (NASDAQ:CGIX), According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the Director of Cancer Genetics Inc, Pappajohn John, had purchased 5,589 shares in a transaction dated on ...